Erratum: Glucans from the edible mushroom Pleurotus pulmonarius inhibit colitis-associated colon carcinogenesis in mice (Journal of Gastroenterology (2012) 47 (504-518) DOI: 10.1007/s00535-011-0514-7);Glucans from the edible mushroom Pleurotus pulmonarius inhibit colitis-associated colon carcinogenesis in mice

Journal of Gastroenterology

Volumn 47, Issue 5, 2012, Pages 504-518

  Lavi, Iris ^a   Nimri, Lili ^a   Levinson, Dana ^a   Peri, Irena ^a   Hadar, Yitzhak ^a   Schwartz, Betty ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Apoptosis; Carcinogenesis; Colon; Glucans; Pleurotus pulmonarius

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CYCLINE; CYTOCHROME C; FUNGAL EXTRACT; GLUCAN; I KAPPA B ALPHA; NUCLEAR FACTOR; PLEUROTUS PULMONARIUS EXTRACT; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABERRANT CRYPT FOCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STRAIN HCT116; CELL STRAIN HT29; COLITIS; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; EDIBLE MUSHROOM; FRUITING BODY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MICROADENOMA; MOUSE; MYCELIUM; NONHUMAN; PLEUROTUS; PLEUROTUS PULMONARIUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 84865139394     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-012-0658-0     Document Type: Erratum

References (48)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108. (Pubitemid 40372904)
2. Gunter MJ, Stolzenberg-Solomon R, Cross AJ, Leitzmann MF, Weinstein S, Wood RJ, Virtamo J, Taylor PR, Albanes D, Sinha R. A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res. 2006;66:2483-7.
3. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48: 526-35. (Pubitemid 32234798)
4. Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, Williams C, Price A, Talbot I, Forbes A. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451-9. (Pubitemid 38182302)
5. Lavi I, Levinson D, Peri I, Nimri L, Hadar Y, Schwartz B. Orally administered glucans from the edible mushroom Pleurotus pul-monarius reduce acute inflammation in dextran sulfate sodium-induced experimental colitis. Br J Nutr. 2010;103:393-402.
6. Borchers AT, Krishnamurthy A, Keen CL, Meyers FJ, Gershwin ME. The immunobiology of mushrooms. Exp Biol Med (May-wood). 2008;233:259-76. (Pubitemid 351328568)
7. Grube BJ, Eng ET, Kao YC, Kwon A, Chen S. White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation. J Nutr. 2001;131:3288-93. (Pubitemid 33136151)
8. Thyagarajan A, Zhu J, Sliva D. Combined effect of green tea and Ganoderma lucidum on invasive behavior of breast cancer cells. Int J Oncol. 2007;30:963-9.
9. Wu D, Pae M, Ren Z, Guo Z, Smith D, Meydani SN. Dietary supplementation with white button mushroom enhances natural killer cell activity in C57BL/6 mice. J Nutr. 2007;137:1472-7. (Pubitemid 46855488)
10. Yu CH, Kan SF, Shu CH, Lu TJ, Sun-Hwang L, Wang PS. Inhibitory mechanisms of Agaricus blazei Murill on the growth of prostate cancer in vitro and in vivo. J Nutr Biochem. 2009;20: 753-64.
11. Kobayashi H, Yoshida R, Kanada Y, Fukuda Y, Yagyu T, Inagaki K, Kondo T, Kurita N, Suzuki M, Kanayama N, et al. Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model. J Cancer Res Clin Oncol. 2005;131:527-38. (Pubitemid 41215308)
12. Lee IS, Nishikawa A. Polyozellus multiplex, a Korean wild mushroom, as a potent chemopreventive agent against stomach cancer. Life Sci. 2003;73:3225-34. (Pubitemid 37237575)
13. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science. 2004;305:626-9. (Pubitemid 39006738)
14. Shi Y. A structural view of mitochondria-mediated apoptosis. Nat Struct Biol. 2001;8:394-401. (Pubitemid 32381284)
15. Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A, Burg J, Strand S, Kiesslich R, Huber S, et al. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity. 2004;21:491-501. (Pubitemid 39370505)
16. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M. IKKbeta links inflammation and tumori-genesis in a mouse model of colitis-associated cancer. Cell. 2004; 118:285-96. (Pubitemid 39061110)
17. Tanaka T, de Azevedo MB, Duran N, Alderete JB, Epifano F, Genovese S, Tanaka M, Curini M. Colorectal cancer chemopre-vention by 2 beta-cyclodextrin inclusion compounds of auraptene and 4-geranyloxyferulic acid. Int J Cancer. 2010;126:830-40.
18. Kerem Z, Hadar Y. Effect of manganese on preferential degradation of lignin by Pleurotus ostreatus during solid-state fermentation. Appl Environ Microbiol. 1995;61:3057-62.
19. Lavi I, Levinson D, Peri I, Tekoah Y, Hadar Y, Schwartz B. Chemical characterization, antiproliferative and antiadhesive properties of polysaccharides extracted from Pleurotus pulmo-narius mycelium and fruiting bodies. Appl Microbiol Biotechnol. 2010;85(6):1977-90.
20. Loher F, Bauer C, Landauer N, Schmall K, Siegmund B, Lehr HA, Dauer M, Schoenharting M, Endres S, Eigler A. The inter-leukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation. J Pharmacol Exp Ther. 2004;308:583-90. (Pubitemid 38134220)
21. Schwartz B, Birk Y, Raz A, Madar Z. Nutritional-pharmacological combinations\a novel approach to reducing colon cancer incidence. Eur J Nutr. 2004;43:221-9. (Pubitemid 39222534)
22. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopatho-logic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69:238-49.
23. Kim JK, Oh SM, Kwon HS, Oh YS, Lim SS, Shin HK. Anti-inflammatory effect of roasted licorice extracts on lipopoly-saccharide-induced inflammatory responses in murine macro-phages. Biochem Biophys Res Commun. 2006;345:1215-23. (Pubitemid 44218790)
24. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931-68.
25. Kodama N, Murata Y, Nanba H. Administration of a polysac-charide from Grifola frondosa stimulates immune function of normal mice. J Med Food. 2004;7:141-5. (Pubitemid 38891066)
26. Yan B, Wang H, Rabbani ZN, Zhao Y, Li W, Yuan Y, Li F, Dewhirst MW, Li CY. Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation. Cancer Res. 2006;66:11565-70. (Pubitemid 46094163)
27. Kim YJ, Hong KS, Chung JW, Kim JH, Hahm KB. Prevention of colitis-associated carcinogenesis with infliximab. Cancer Prev Res (Phila). 2010;3:1314-33.
28. Cohen SM, Ellwein LB. Cell proliferation in carcinogenesis. Science. 1990;249:1007-11.
29. Kellett M, Potten CS, Rew DA. A comparison of in vivo cell proliferation measurements in the intestine of mouse and man. Epithelial Cell Biol. 1992;1:147-55.
30. McGarrity TJ, Peiffer LP, Colony PC. Cellular proliferation in proximal and distal rat colon during 1, 2-dimethylhydrazine-induced carcinogenesis. Gastroenterology. 1988;95:343-8.
31. Barnes CJ, Cameron IL, Hardman WE, Lee M. Non-steroidol anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis. Br J Cancer. 1998;77:573-80. (Pubitemid 28059464)
32. Essers J, Theil AF, Baldeyron C, van Cappellen WA, Houts-muller AB, Kanaar R, Vermeulen W. Nuclear dynamics of PCNA in DNA replication and repair. Mol Cell Biol. 2005;25:9350-9. (Pubitemid 41507836)
33. Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer. 2005;5:876-85. (Pubitemid 41746032)
34. Fullerton SA, Samadi AA, Tortorelis DG, Choudhury MS, Mal-louh C, Tazaki H, Konno S. Induction of apoptosis in human prostatic cancer cells with beta-glucan (Maitake mushroom polysaccharide). Mol Urol. 2000;4:7-13. (Pubitemid 30238683)
35. Hu H, Zhang Z, Lei Z, Yang Y, Sugiura N. Comparative study of antioxidant activity and antiproliferative effect of hot water and ethanol extracts from the mushroom Inonotus obliquus. J Biosci Bioeng. 2009;107:42-8.
36. Zhang M, Chiu LC, Cheung PC, Ooi VE. Growth-inhibitory effects of a beta-glucan from the mycelium of Poria cocos on human breast carcinoma MCF-7 cells: cell-cycle arrest and apoptosis induction. Oncol Rep. 2006;15:637-43.
37. Joo YE, Karrasch T, Muhlbauer M, Allard B, Narula A, Herfarth HH, Jobin C. Tomato lycopene extract prevents lipopoly-saccharide-induced NF-kappaB signaling but worsens dextran sulfate sodium-induced colitis in NF-kappaBEGFP mice. PLoS One. 2009;4:e4562.
38. Paul G, Bataille F, Obermeier F, Bock J, Klebl F, Strauch U, Lochbaum D, Rummele P, Farkas S, Scholmerich J, et al. Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis. Clin Exp Immunol. 2005;140:547-55. (Pubitemid 40813967)
39. Hengartner MO. The biochemistry of apoptosis. Nature. 2000; 407:770-6.
40. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997;275: 1129-32. (Pubitemid 27097312)
41. Matsuyama S, Llopis J, Deveraux QL, Tsien RY, Reed JC. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat Cell Biol. 2000;2:318-25.
42. Cai J, Jones DP. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J Biol Chem. 1998;273: 11401-4. (Pubitemid 28272028)
43. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998; 281:1309-12. (Pubitemid 28406816)
44. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998;94:481-90. (Pubitemid 28391864)
45. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999;13: 1899-911. (Pubitemid 29407357)
46. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Kors-meyer SJ. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001;292:727-30. (Pubitemid 32385543)
47. Zhu T, Guo J, Collins L, Kelly J, Xiao ZJ, Kim SH, Chen CY. Phellinus linteus activates different pathways to induce apoptosis in prostate cancer cells. Br J Cancer. 2007;96:583-90.
48. Zong WX, Lindsten T, Ross AJ, MacGregor GR, Thompson CB. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 2001;15:1481-6. (Pubitemid 32552527)